Related Experiment Video
Updated: May 6, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
[NO-dependent mechanisms of cardioprotective activity of MT preparation during course administration to SHR rats]
Abstract:
Chronic (15 days) single daily intraperitoneal insertion of the new preparation MT (5 mg/kg) and metoprolol (10 mg/kg) into SHR rats leads to the same decrease (18%) in arterial pressure. In addition, MT exhibits a cardioprotective effect because of NO-mimetic properties, increasing NO formation in myocardium via increasing general NOS activity and eNOS expression. MT normalizes iNOS expression in myocardium mitochondria and decreases nitrotyrosine (nitrosation stress marker) formation. At the same time, the reference preparation metoprolol did not exhibit NO-mimetic properties in myocardium of SHR rats.
Insights
The new preparation MT lowers arterial pressure and protects the heart by mimicking nitric oxide (NO) effects. Unlike metoprolol, MT increases NO formation and reduces nitrosation stress in SHR rats.
Area of Science:
- Pharmacology
- Cardiovascular Research
- Biochemistry
Context:
- Spontaneously Hypertensive Rats (SHR) are a common model for studying hypertension.
- Chronic hypertension leads to cardiovascular damage, including myocardial dysfunction.
- Nitric oxide (NO) plays a crucial role in regulating blood pressure and cardiac function.
Purpose:
- To investigate the effects of a new preparation, MT, on arterial pressure and myocardial function in SHR rats.
- To compare the NO-mimetic properties of MT with metoprolol, a known antihypertensive drug.
- To elucidate the mechanisms underlying MT's potential cardioprotective effects.
Summary:
- Chronic administration of MT (5 mg/kg) and metoprolol (10 mg/kg) to SHR rats resulted in an equivalent 18% reduction in arterial pressure.
- MT demonstrated significant cardioprotective effects, attributed to its NO-mimetic properties, by enhancing NO formation in the myocardium through increased general Nitric Oxide Synthase (NOS) activity and eNOS expression.
- MT also normalized inducible NOS (iNOS) expression in myocardial mitochondria and decreased nitrotyrosine formation, a marker of nitrosation stress, whereas metoprolol lacked these NO-mimetic properties in the rat myocardium.
Impact:
- MT shows promise as a novel therapeutic agent for hypertension with added cardioprotective benefits.
- The findings highlight the importance of NO-mimetic properties in antihypertensive drugs for mitigating cardiovascular damage.
- This study provides a mechanistic basis for MT's efficacy and suggests its potential for clinical development in managing hypertensive cardiovascular disease.
More Related Videos
08:01Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System
Published on: June 11, 2020
09:38Simultaneous Isolation of High Quality Cardiomyocytes, Endothelial Cells, and Fibroblasts from an Adult Rat Heart
Published on: May 19, 2017
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Inotropic Agents